Protagonist Therapeutics, Inc Payments of Debt Issuance Costs
Protagonist Therapeutics, Inc (PTGX) reported Payments of Debt Issuance Costs of $14.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2023-03-15
- Protagonist Therapeutics, Inc payments of debt issuance costs for the quarter ending 2020-12-31 was $0.00.
- Protagonist Therapeutics, Inc payments of debt issuance costs for the quarter ending 2020-09-30 was $0.00.
- Protagonist Therapeutics, Inc payments of debt issuance costs for the quarter ending 2020-06-30 was $7.00K.
- Protagonist Therapeutics, Inc payments of debt issuance costs for the quarter ending 2020-03-31 was $7.00K.
- Protagonist Therapeutics, Inc payments of debt issuance costs for fiscal 2020 was $14.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 derived: sum of 2 quarters · filed 2023-03-15 | $7.00K derived: sum of 3 quarters · filed 2023-03-15 | $14.00K 10-K · filed 2023-03-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $7.00K derived: sum of 2 quarters · filed 2021-11-03 | $14.00K 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $14.00K 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |